Literature DB >> 11864797

Lost income and work limitations in persons with chronic respiratory disorders.

Marcia M Ward1, Harold S Javitz, W McFate Smith, Melissa A Whan.   

Abstract

Chronic respiratory diseases are prevalent, disabling, and rank fifth in terms of cost of illness among major disease groups; however, the degree of work loss and lost income is largely unknown. Lost wages in adults with chronic respiratory conditions were calculated from the Survey of Income and Program Participation (SIPP). The National Health Interview Survey (NHIS) was used to estimate work loss and limitations in specific chronic respiratory conditions, including allergic rhinitis, asthma, chronic bronchitis, and emphysema. The SIPP indicated that adults with chronic respiratory conditions average $3,143 annual earnings loss ($5,272 for those between the ages of 25 and 64 and $1,267 for those over age 65). The NHIS indicated that 19.9% of persons with chronic respiratory conditions report being unable to work. Comparisons across respiratory diseases are made.

Entities:  

Mesh:

Year:  2002        PMID: 11864797     DOI: 10.1016/s0895-4356(01)00468-1

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

Review 1.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 2.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Predictors of changes in sick leave in workers with asthma: a follow-up study.

Authors:  Cécile R L Boot; Jan H M M Vercoulen; Joost W J van der Gulden; Karin H Orbon; Jos M Rooijackers; Chris van Weel; Hans Th M Folgering
Journal:  Int Arch Occup Environ Health       Date:  2005-10-12       Impact factor: 3.015

4.  Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings--evidence from annual registry data in 1990-2005.

Authors:  K Steen Carlsson; M Landin-Olsson; L Nyström; H J Arnqvist; J Bolinder; J Ostman; S Gudbjörnsdóttir
Journal:  Diabetologia       Date:  2009-12-18       Impact factor: 10.122

5.  Asthma and chronic obstructive pulmonary disease: differences between workers with and without sick leave.

Authors:  C R L Boot; J W J van der Gulden; K H Orbon; J H M M Vercoulen; R Akkermans; C van Weel; H T M Folgering
Journal:  Int Arch Occup Environ Health       Date:  2004-04-24       Impact factor: 3.015

6.  Work life of persons with asthma, rhinitis, and COPD: a study using a national, population-based sample.

Authors:  Edward Yelin; Patricia Katz; John Balmes; Laura Trupin; Gillian Earnest; Mark Eisner; Paul Blanc
Journal:  J Occup Med Toxicol       Date:  2006-02-02       Impact factor: 2.646

7.  Alterations in psychosocial health of people affected by asbestos poisoning.

Authors:  Miguel Clemente; Adela Reig-Botella; Juan Carlos Prados
Journal:  Rev Saude Publica       Date:  2015       Impact factor: 2.106

Review 8.  The global impact of non-communicable diseases on macro-economic productivity: a systematic review.

Authors:  Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

Review 9.  Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States.

Authors:  Jeetvan G Patel; Saurabh P Nagar; Anand A Dalal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-03-19

Review 10.  The Danish National Database for Asthma: establishing clinical quality indicators.

Authors:  Susanne Hansen; Benjamin Hoffmann-Petersen; Asger Sverrild; Elvira V Bräuner; Jesper Lykkegaard; Uffe Bodtger; Lone Agertoft; Lene Korshøj; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.